We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Jack Latham, Blood-Processing Pioneer, Dies at 95

By Labmedica staff writers
Posted on 27 Aug 2003
Allen Latham Jr., who helped perfect a device that would revolutionize transfusion methods by using centrifugal force to separate blood into its various components, died recently at his home in Jamaica Plain (MA, USA). More...


Known as Jack, Mr. Latham graduated from the Massachusetts Institute of Technology in 1930. He became interested in blood processing following the failed transfusion of his donated blood to a friend following an industrial accident. Early on, he worked with Edwin Land at a company that later became Polaroid on the development of polarization sheets. Later, he worked on low-temperature refrigeration at the industrial research firm of Arthur D. Little. He began to collaborate with Prof. Edwin J. Cohn at Harvard in the 1950s on the use of centrifugal force to separate blood components.

Later, Mr. Latham developed a disposable version of the centrifugal device, known as the Latham bowl, as well as other instruments for the collection and separation of blood into red cells, white cells, plasma and platelets. By using the bowl, doctors could clean and reuse a surgical patient's own blood, reducing contamination risks. In 1971, Mr. Latham founded a company called Haemonetics Corp. in Braintree (MA, USA), where he continued to develop blood-processing devices and to market them. His efforts helped to make platelet donations more efficient and improved the ability to wash out toxins.

New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.